BIOPORTO DIAGNOSTICS A/S
18645882ActiveBioPorto develops diagnostic tools for early kidney injury detection.
Publicly traded biotechnology and medical device companybioporto.com
Yleiskatsaus
- 25
- Työntekijät
- Tuntematon
- Liikevaihto
- 1995
- Perustettu
Avainpäättäjät
Klaus Juhl Wulff
CFO
@bioporto.com+45255XXXXX
Gry Husby Larsen
EVP & Chief Legal Officer
Donna Haire
Board Member
Mats Thorén
Board Member
+9 lisää yhteystietoja Funnelfeedrissä
Kuvaus
BioPorto is an in vitro diagnostics company dedicated to improving patient outcomes through the development of actionable biomarkers. The company specializes in the NGAL biomarker, which is used to aid in the risk assessment and diagnosis of Acute Kidney Injury (AKI). By leveraging expertise in anti...
CALPRO AS